MAPT and Alzheimer disease: Future studies need to explore the concrete interaction between lncRNA-- RP11-59J16.2 and MCM2, and the downstream mechanism of MCM2 on Tau phosphorylation, cell apoptosis and cell-cycle activation in AD.